References
[1]. R.Wise, T.Hart, O.Cars, M.Streulens, R.Helmuth, P.Huovinen, & M.Sprenger. “Antimicrobial resistance. Is a major threat to public health”, British Medical Journal, Vol.317, pp.609-10, 1998.
[2]. H.C. Wegener, N.Frimodt-Molle. “Reducing the use of antimicrobial agents in animals and man”. Journal of Medical Microbiology, Vol.49, pp.111-3, 2000.
[3]. K. Mølbak, D.L. Baggesen, F.M. Aarestrup, J.M. Ebbesen, J.Engberg, K.Frydendahl, P.Gerner-Smidt, A.M. Petersen, H.C. Wegener, “An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104”, New England Journal of Medicine, Vol.341, Issue.19, pp.1420-5,1999.
[4]. Centers for Disease Control and Prevention (CDC. Outbreak of multidrug-resistant Salmonella newport-United States, January-April 2002. MMWR. Morbidity and mortality weekly report. 51(25), pp.545, 2002.
[5]. K.E. Smith, J.M. Besser, C.W. Hedberg, F.T. Leano, J.B. Bender, J.H. Wicklund, B.P. Johnson, K.A. Moore, M.T. Osterholm, “Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992–1998”, New England Journal of Medicine,Vol.340, Issue.20, pp.1525-32, 1999.
[6]. S.C. Rankin, H. Aceto, J. Cassidy, J.Holt, S.Young, B.Love, D. Tewari, D.S. Munro, C.E. Benson, “Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania”, Journal of Clinical Microbiology, Vol.40, Issue.12, pp.4679-84, 2002.
[7]. P.L.Winokur, A.Brueggemann, D.L. DeSalvo, L.Hoffmann, M.D.Apley, E.K. Uhlenhopp, M.A. Pfaller, G.V. Doern, “Animal and human multidrug-resistant, cephalosporin-resistantSalmonella isolates expressing a plasmid-mediated CMY-2 AmpC β-lactamase”, Antimicrobial agents and chemotherapy, Vol.44, Issue10, pp.2777-83, 2000.
[8]. Y.Helmy, H.El-Adawy, E.Abdelwhab, “A comprehensive review of common bacterial, parasitic and viral zoonoses at the human–animal interface in Egypt”, Pathogens, Vol.6, pp.33, 2017. doi: 10.3390/pathogens6030033.
[9]. L S Mian, H Maag, J V Tacal, “Isolation of Salmonella from muscoid flies at commercial animal establishments in San Bernardino County, California”, Journal of Vector Ecology. Vol.27, pp.82–85, 2002.
[10]. J.Taylor and J.McCoy. “Salmonella”, In H. Reimann (ed.), Foodborne infections and intoxications. Academic Press, New York, pp.3-71,1969.
[11]. J.P. Bryan and W.M. Scheld. “Therapy of experimental meningitis due to Salmonella enteritidis,” Antimicrobial Agents and Chemotherap,. Vol 36, Issue.5, pp.949–54,1992.
[12]. C.E. Cherubin, R. H. Eng, S. M. Smith, and E. J. Goldstein. “Cephalosporin therapy for salmonellosis: questions of efficacy and cross resistance with ampicillin”, Archives of internal medicine, Vol.46, Issue.11, pp.2149–52, 1986.
[13]. E.F. Dunne, P.D. Fey, P. Kludt, R. Reporter, F. Motashari, P. Shillam, J. Wicklund, C. Miller, B. Holland, K. Stamey, T. J. Barrett, J.K. Rasheed, F.C. Tenover, E.F. Ribot, and F.J. Angulo, “Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC B-lactamase”, JAMA, Vol.284, pp.3151–56,2000.
[14]. K. Bush, “Extended-spectrum beta-lactamases in North America, 1987–2006”. Clinical Microbiology and Infection, Vol.14(Suppl 1), pp.134 –143, 2008.
[15]. A. Carattoli. “Animal reservoirs for extended spectrum betalactamase producers”, Clinical Microbiology and Infection, Vol.14(Suppl 1), pp.117–123,2008.
[16]. L.C. Martin, E.K, Weir, C.Poppe, R.J. Reid-Smith, P. Boerlin, “Characterization of blaCMY-2 plasmids in Salmonella and Escherichia coli isolates from food animals in Canada”, Applied Environmental Microbiology, Vol.78, pp.1285–87, 2012.
[17]. L.Dutil, R.Irwin, R.Finley, L.K.Ng, B. Avery, P. Boerlin, A.M. Bourgault, L.Cole, D.Daignault, A.Desruisseau, W. Demczuk, L. Hoang, G.B. Horsman, J. Ismail, F.Jamieson, A.Maki, A.Pacagnella, D.R. Pillai, 2010. “Ceftiofur resistance in Salmonella enterica serovar Heidelberg from chicken meat and humans, Canada’, Emerging Infectious Diseases,Vol.16, pp.48 –54,2010.
[18]. J.D. Pitout, K.B. Laupland, “Extended-spectrum beta – lactamase – producing Enterobacteriaceae: an emerging public-health concern”, Lancet Infectious Diseases, Vol.8, pp.159–166, 2008. doi: 10.1016/S1473-3099(08)70041-0.
[19]. K. Bush, G.A. Jacoby. “Updated functional classification of β-lactamases”, Antimicrobial Agents and Chemotherapy, Vol.54, pp.969–76,2010. doi: 10.1128/AAC.01009-09.
[20]. G.A.Jacoby, “AmpC β-lactamases”, Clinical Microbiology Reveiws, Vol.22, pp.161–182, 2009. doi: 10.1128/CMR.00036-08.
[21]. Y. Pfeifer, A.Cullik, W. Witte, “Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens”, International Journal of Medical Microbiology, Vol.300, pp.371–79, 2010. doi: 10.1016/j.ijmm.2010.04.005.
[22]. S.M. Abd-Elghany, K.I. Sallam, A.Abd-Elkhalek, T. Tamura, “Occurrence, genetic characterization and antimicrobial resistance of Salmonella isolated from chicken meat and giblets”, Epidemiology and Infection, Vol.143, pp.997–1003, 2015. doi: 10.1017/S0950268814001708.
[23]. R.M. Gharieb, Y.H.Tartor, M.H. Khedr, “Non-typhoidal Salmonella in poultry meat and diarrhoeic patients: prevalence, antibiogram, virulotyping, molecular detection and sequencing of class I integrons in multidrug resistant strains”.Gut Pathogens, Vol.7, pp.15–81, 2015. doi: 10.1186/s13099-015-0081-1.
[24]. H.A. Ahmed, F.I. El-Hofy, S.M. Shafik, M.A. Abdelrahman, G.A. Elsaid, “Characterization of virulence-associated genes, antimicrobial resistance genes, and class 1 integrons in Salmonella enterica serovar Typhimurium isolates from chicken meat and humans in Egypt”, Foodborne Pathogens and Diseases, Vol.13, pp.281–88,2016. doi: 10.1089/fpd. 2015.2097.
[25]. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard. 11th ed. Clinical and Laboratory Standards Institute, Wayne, PA; 2012
[26]. L. Drieux, F. Brossier, W. Sougakoff, V.Jarlier, “Phenotypic detection of extended-spectrum b-lactamase production in Enterobacteriaceae: review and bench guide”, Clinical Microbiology and Infection, Vol.14 (Suppl. 1), pp.90–103,2008.
[27]. H.C. Bimboim, J.Doly, “A rapid alkaline extraction procedure for screening recombinant plasmid DNA”. Nucleic acids research. Vol.7(6), pp.1513-23, 1979.
[28]. M.M Ehlers, C.Veldsman, E.P. Makgotlho, M.G. Dove, A.A Hoosen, M.M. Kock, “Detection of bla SHV, bla TEM and bla CTX-M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital”, FEMS Immunology & Medical Microbiology, Vol.56(3), pp.191-6, 2009.
[29]. R.E. Ziech, C. Lampugnani, A.P. Perin, M.J. Sereno, R.A. Sfaciotte, C.Viana, V.M. Soares, J.P. Pinto, L. dos Santos Bersot, “Multidrug resistance and ESBL-producing Salmonella spp. isolated from broiler processing plants”, Brazilian Journal of Microbiology, Vol47(1),pp.191-5, 2016.
[30]. W. Rabsch, H. Tschäpe, A .J. Bäumler, “Non-typhoidal salmonellosis: emerging problems”, Microbes and infection, Vol.3(3), pp.237-47, 2001.
[31]. P. Butaye, G.B. Michael, S. Schwarz, T.J. Barrett, A. Brisabois, D.G.White, “The clonal spread of multidrug-resistant non-typhi Salmonella serotypes”, Microbes and Infection, Vol.8(7),pp.1891-7, 2006.
[32]. R. Ranjbar, G.M. Giammanco, S. Farshad, P. Owlia, A. Aleo, C. Mammina, “Serotypes, antibiotic resistance, and class 1 integrons in Salmonella isolates from pediatric cases of enteritis in Tehran, Iran”. Foodborne Pathogens and Disease. Vol.8(4), pp.547-53, 2011.
[33]. C. M. Parry, “Antimicrobial drug resistance in Salmonella enterica”, Current Opinion in Infectious Diseases, Vol.16(5), pp.467-72, 2003.
[34]. I. Rychlik, D. Gregorova, H. Hradecka, “Distribution and function of plasmids in Salmonella enterica”, Veterinary Microbiology, Vol.112(1), pp.1-0, 2006.
[35]. A. Zioga, J. M. Whichard, S. D. Kotsakis, L. S. Tzouvelekis, E. Tzelepi, and V. Miriagou, “CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids”, Antimicrobial Agents and Chemotherapy, Vol.53, pp.1256, 2009.